What is the optimal duration of adjuvant therapy in colon cancer?
Shields, A.F.
Clinical Advances in Hematology and Oncology H&o 15(10): 734-738
2017
ISSN/ISBN: 1543-0790 PMID: 29040251 Document Number: 694378
Document emailed within 1 workday
Related Documents
Kadakia, K.C.; Worrilow, W.M.; Coley, H.; Salem, M.E. 2019: Optimal duration of adjuvant therapy for stage IIi colon cancer Clinical Advances in Hematology and Oncology: H&o 17(5): 289-298Baldini, E.; Prochilo, T. 2004: The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: what kind of evidence? I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S79-S80
Harvey, V.J. 1991: Adjuvant therapy of colon cancer: what should we be doing New Zealand Medical Journal 104(915): 280-281
Harvey, V.J. 1991: Adjuvant therapy of colon cancer: what should we be doing New Zealand Medical Journal 104(915): 280-281
Grady, E.D. 1984: Adjuvant therapy of Dukes' C colon cancer by intra-arterial P-32 colloid for internal radiation therapy of the liver American Surgeon 50(9): 488-492
Wils, J. 2001: Adjuvant therapy for colon cancer: the European experience Tumori 87(1 Suppl 1: S85
Mettu, N.B.; Hurwitz, H.; Hsu, D.S. 2013: Use of molecular biomarkers to inform adjuvant therapy for colon cancer Oncology 27(8): 746-754
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Mitomi, T.; Tsuchiya, S.; Iijima, N.; Aso, K.; Suzuki, K.; Nishiyama, K.; Amano, T.; Takahashi, T.; Murayama, N.; Oka, H. 1989: Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. the Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2241-2249
Alcocer, F.; López, E.; Calva, J.J.; Herrera, M.F. 2001: Antibiotic therapy in secondary peritonitis: towards a definition of its optimal duration Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 53(2): 121-125
Yamaguchi, M.; Fukuyama, Y.; Ichinose, Y. 2003: Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 203-208
Fuchs, C.S.; Mayer, R.J. 1995: Adjuvant chemotherapy for colon and rectal cancer Seminars in Oncology 22(5): 472-487
Yaich, A.; Khanfir, A.; Bayrouti, M.I.; Frikha, M. 2015: Adjuvant chemotherapy in colon cancer. about 119 cases La Tunisie Medicale 93(4): 242-247
Raskov, H.H. 1996: Adjuvant systemic chemotherapy in colon cancer Ugeskrift for Laeger 158(9): 1222-1227
Lee, J.J.; Chu, E. 2018: The Adjuvant Treatment of Stage IIi Colon Cancer: Might Less be More? Oncology 32(9): 437
Nelson, H. 1992: Advances in adjuvant chemotherapy for colon cancer Minerva Chirurgica 47(5): 213-222
Schlag, P.M. 1994: Adjuvant systemic chemo- or immunotherapy of colon cancer Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 65(6): 503-508
Mamounas, E.P.; Wieand, H.S.; Jones, J.; Wickerham, D.L.; Wolmark, N. 1997: Future directions in the adjuvant treatment of colon cancer Oncology 11(9 Suppl 10: 44-47
Fujinaka, R.; Otowa, Y.; Yokoo, H.; Arai, K.; Murata, K.; Mii, Y.; Kakinoki, K.; Oka, S.; Kuroda, D. 2019: Adjuvant Chemotherapy for High-Risk Stage Ⅱ Colon Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(8): 1327-1329
Miyake, Y.; Ikeda, K.; Osawa, H.; Nagase, H.; Hoshi, M.; Doi, T.; Makari, Y.; Oshima, S.; Iijima, S.; Kurokawa, E.; Kikkawa, N. 2012: Fluoropyrimidines with oxaliplatin(L-OHP) as an adjuvant chemotherapy for Stage IIi colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2161-2163